Banner Image
Banner Image


Upcoming Events

Events Image
Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities (J4)
The 2020 Keystone Symposia Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities in conjunction with the joint conference, Gene Regulation: From Mechanisms to Disease, co-organized by Karen Adelman and Patrick Cramer, will highlight state-of-the art advances in methods, mechanistic insights, and drug discovery efforts across these interrelated fields. Furthermore, results from exome- and genome-wide sequencing efforts point toward major roles for chromatin regulatory machinery in cancer. These data emphasize the immediate need for
Press BG


Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation

Mayilaadumveettil Nishana, Javier Rodriguez-Hernaez, Caryn Ha, Erica Chio, Elphege P. Nora, Sana B. Badri, Andreas Kloetgen, Benoi..

Six new reference-quality bat genomes illuminate the molecular basis and evolution of bat adaptations

David Jebb, Zixia Huang, Martin Pippel, Graham M. Hughes, Ksenia Lavrichenko, Paolo Devanna, Sylke Winkler, Lars S. Jermiin, Emilia C. Skirmuntt, Aris Katzourakis, Lucy Burkitt-Gray, David A. Ray, Kev..

NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains

Priscillia Lhoumaud, Sana Badri, Javier Rodriguez-Hernaez, Theodore Sakellaropoulos, Gunjan Sethia, Andreas Kloetgen, MacIntosh Cornwell, Sourya Bhattacharyya, Ferhat Ay, Richard Bonneau, Aristotelis ..

Testimonial Image
Testimonial Image
Testimonial Image

We have been very happy with the Arima-HiC kit. The Arima-HiC protocol is days quicker than our previous lab’s protocol. All together, better quality data for less effort.

– Eileen Furlong, PhD.

Head of Genome Biology Unit – European Molecular Biology Laboratory (EMBL)

Arima Genomics is an integral technology partner of the G10K consortium and Phase I of the VGP project. Arima was selected for Phase I based on the quality of their data, proven by their ability to generate reproducible and high-quality data despite variability in input sample quality and quantity. 

– Gene Myers, PhD.

G10K Council Member and Director at Max-Planck Institute of Molecular Cell Biology and Genetics, Dresden

When we tested Arima-HiC kit in our hands, we consistently got very high-quality libraries. Particularly, the fraction of inter-chromosomal reads is reduced.

– Daan Noordermeer, PhD.

Group Leader of CNRS Chromatin Dynamics Group